Healthcare Industry News: vascular access
News Release - January 13, 2010
B. Braun Introduces WHIN(R) Safe Huber NeedleHelps Protect Against Needle-stick Injuries, Blood and Fluid Exposure
BETHLEHEM, Pa., Jan. 13 -- (Healthcare Sales & Marketing Network) -- B. Braun Medical Inc. (B. Braun) has launched its new safe and easy-to-use WHINŽ Safe Huber Needle, an implantable port access device that integrates the features of two safety devices in a single Huber Needle and provides clinicians with advanced protection from needle-stick injuries and expelled blood and fluid.
There are three models of the WHINŽ Safe Huber Needle -- a standard model, a model with a needle-free injection site and a model with an open Y-injection site. With an easy-to-dress and intuitive design, the device includes a safety shield that covers the needle tip as it is withdrawn, ensuring both clinician and patient safety.
"The key to the WHINŽ Safe Huber Needle is that it requires minimal change in technique on the part of clinicians," said Tom Sutton, Director of Marketing vascular access for B. Braun Medical Inc. "That means it can be immediately deployed to provide added measures of safety."
B. Braun's WHINŽ Safe Huber Needle Web site, www.whinsafe.bbraunusa.com, provides information on the device as well as information on best practices for clinicians as part of B. Braun's "Sharing ExpertiseŽ" philosophy.
"The Web site offers clinicians a focused, easily accessible way to obtain product information as well as information on how the WHINŽ Safe Huber Needle can enhance clinician and patient safety," added Sutton.
The WHINŽ Safe Huber Needle is one product in a comprehensive line of safe, environmentally responsible B. Braun oncology infusion therapy products. These include pumps that enhance IV safety at home and in clinic settings; PVC-free and DEHP-free IV bags that reduce patient exposure to harmful plasticizers and help healthcare facilities meet their environmental objectives; IV sets and UV-resistant tubing; needle-free IV systems; and IV catheters and Huber needles. The WHINŽ Safe Huber Needle will be offered to oncology outpatient centers, home infusion therapy and hospital-based oncology facilities.
B. Braun also adds value to its oncology infusion therapy product line with clinical analysis programs to improve patient and practitioner safety, clinical mentoring programs as well as programs for clinicians and pharmacists and 24/7 clinical and technical support.
About B. Braun
B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company's "Sharing ExpertiseŽ" philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.
Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, e-mail us at firstname.lastname@example.org or visit B. Braun at www.bbraunusa.com.
Source: B. Braun Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.